FDA Inspection 1203381 — ACS Dobfar S.P.A.
The FDA completed an inspection of ACS Dobfar S.P.A. on Apr 8, 2022 in Teramo, San Nicolo A Tordino. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 8, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Teramo, San Nicolo A Tordino (Italy)
Additional Details
Mutual Recognition Agreement (MRA)